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Objective: The aim of this study was to investigate the knowledge of orthopedic
manual therapists (OMTs) regarding context factors (CFs) capable of triggering nocebo
effects during the treatment and how this knowledge is related to their socio-
demographic features.
Design: A cross-sectional online survey.
Setting: National.
Main Outcome Measures: A 20 items questionnaire composed by open-ended and
closed single-choice questions was administered to explore: (a) socio-demographic
variables (10 questions); (b) the relation between different CFs and nocebo-related
effects (2 questions); and (c) the knowledge of participants about nocebo-related effects
and how they managed them in the clinical practice (8 questions).
Participants: 1288 OMTs were recruited from the database of the Master in
Rehabilitation of Musculoskeletal Disorders (MRDM) of the University of Genova from
March to May 2019. Inclusion criteria were: (a) to possess a valid email account; (b) to
understand and use as a native language the Italian; (c) to be graduated as OMTs; and
(d) to be employed as physiotherapists specialized-OMTs during the survey.
Results: 791 responses were received (61.4%); 473 of them were male (59.8%), with
an average age of 31.0 ± 7.1 years. OMTs defined nocebo-related effects as the
psychosocial context effects around therapy and patient with specific biological bases
(72.2%). OMTs know that their clinical practice is pervaded by nocebo-related effects
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(42.5%), triggered by CFs. Participants communicated nocebo-related effects balancing
the positive features of the therapy with the negative ones (50.9%), during the decision of
the therapeutic plan (42.7%). They reported associative learning as the main mechanism
involved in nocebo-related effects (28.8%). OMTs taught and trained patient’s strategies
to manage nocebo-related effects (39.6%) through an evaluation and correction of
patient’s anxieties, doubts and expectations (37.7%). OMTs most frequently considered
themselves to have a “medium” education about nocebo-related effects (48.2%) and
that their management should be taught during bachelor (78.6%).
Conclusion: OMTs believed that nocebo-related effects were present in their clinical
practice and that they can be triggered by CFs.
Keywords: nocebo effect, expectation, physiotherapy (MeSH), contextual factors, pain, placebo effects,
conditioning, survey
INTRODUCTION
Placebo and nocebo-related effects are emerging phenomena of
interest among researchers, scholars and clinicians in orthopedic
manual therapy (Rossettini et al., 2018a). They represent the
result of the positive (placebo) or negative (nocebo) use
of contextual factors (CFs) during the administration of a
therapy (Benedetti, 2013). Contextual factors include physical,
psychological and social elements involved in the clinical
encounter between the patient and the physiotherapist (Di
Blasi et al., 2001) such as: (a) physiotherapist’s features (e.g.,
expertise, reputation); (b) patient’s features (e.g., expectations,
previous experience); (c) patient-physiotherapist relationship
(e.g., verbal communication, posture); (d) treatment features
(e.g., overt therapy, marketing); and (e) healthcare setting
features (e.g., environment, architecture) (Testa and Rossettini,
2016). In the clinical scenario, the interaction between the specific
component of a therapy and the surrounding CFs influences
the subjective therapeutic experience (e.g., pain, fear, anxiety)
triggering placebo or nocebo-related effects (Carlino et al., 2014):
specifically, positive CFs can ameliorate the clinical outcomes,
while negative CFs can amplify patients’ symptoms preventing
their recovery (Wager and Atlas, 2015).
While placebo-related effects have been widely inquired
in orthopedic manual therapy, nocebo-related effects have
been underlined as a new research field that should be
investigated for several reasons (Rossettini et al., 2020). First,
psychobiological explanations have been documented as the
underlying mechanisms of action (e.g., genetic, expectation,
learning) of CFs and evoked nocebo-related effects (Colloca
and Barsky, 2020) capable to exacerbate the perception of a
symptom affecting also the therapeutic relationship (Hansen
and Zech, 2019). Second, specific neurotransmitters (e.g.,
cholecystokinin and cyclooxygenase-prostaglandins activation;
opioid and dopamine deactivation) have been indicated as
mediators involved in CFs and triggered nocebo-related effects
(Frisaldi et al., 2015). Part of these processes are also the
activation of neural pathways (e.g., anterior cingulate cortex,
dorsolateral prefrontal cortex, periaqueductal gray, and spinal
cord) (Darnall and Colloca, 2018). Third, the negative clinical
impact of CFs (e.g., patients’ expectations, beliefs) and induced
nocebo-related effects on therapeutic outcomes has been
highlighted at multiple healthcare levels, resulting in increased
costs, work absenteeism and medicalization (Hallegraeff et al.,
2012; Trinderup et al., 2018).
At the international level, an expert panel has recently
identified as a research priority the knowledge nocebo-related
effects and CFs among clinicians (Evers et al., 2018). To
date, one qualitative study has investigated nocebo-related
effects during the physician-patient communication in Pakistan
(Ashraf and Saaiq, 2014); while two Italian surveys have
explored the knowledge of CFs and placebo-related effects
including physiotherapists specialized in orthopedic manual
therapy and nurses (Rossettini et al., 2018b; Palese et al.,
2019), thus leaving still unexplored this research field. In
particular, OMTs represent an ideal group of clinicians to
be investigated because their practice is intrinsically pervaded
by CFs: during the administration of each therapy (e.g.,
joint mobilization, massage, exercise) they use CFs (e.g.,
verbal and non-verbal communication) influencing the outcome
(Rossettini et al., 2018a).
Thus, the aim of this study was to investigate the knowledge
of orthopedic manual therapists (OMTs) regarding context
factors (CFs) capable of triggering nocebo effects during the




This quantitative cross-sectional survey was conducted
according to the Checklist for Reporting Results of Internet
E-Surveys (CHERRIES) guidelines (Eysenbach, 2004) and
the STrengthening the Reporting of OBservational Studies in
Epidemiology (STROBE; Von Elm et al., 2007), from March
to May 2019. All the procedures were approved by the Liguria
Clinical Experimental Ethics Committee (P.R.236REG2016,
accepted on 19/07/2016).
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Participants and Settings
Participants were Italian physiotherapists specialized and
graduated as OMTs (Rossettini et al., 2018b). Our sample
of OMTs was recruited from the database of the Master
in Rehabilitation of Musculoskeletal Disorders of Genova
University (n = 1288). This higher educational program
represents approximately the totality of the Italian
physiotherapists specialized as OMT. Furthermore, it is the
oldest academic post-graduate program in manual therapy in
Italy (Bologna Working Group, 2005) based upon the standards
established by the International Federation of Orthopedic
Manipulative Physical Therapists (IFOMPT, 2016).
Inclusion criteria were: (a) to possess a valid email account; (b)
to understand and use as a native language the Italian; (c) to be
graduated as OMTs; and (d) to be employed as physiotherapists
specialized-OMTs during the survey. Exclusion criteria were: (a)
to possess an invalid email account; (b) to use and understand
different languages than Italian; (c) to be trained as OMT student
during the survey; and (d) to be employed as non-specialized
physiotherapists.
From the total population target of 1288 OMTs, approximately
516–773 responses were expected, based on previous studies
placebo-related effects and CFs in which the response rate was
from 30 to 60% (Rossettini et al., 2018b; Palese et al., 2019). The
application of these predicted values to the formula for estimating
the sample size using a single population proportion with the
population proportion set at 50.0% produced a two−sided 95.0%
confidence level of 2.2–3.3% points of the true value and a relative




The questionnaire adopted in this study was adapted from a
previous survey published on CFs and placebo-related effects
among OMTs (Rossettini et al., 2018b). Using distinct and
iterative steps, a panel of six experts in nocebo-related effects,
CFs and survey design: (a) modified the meaning of items from
a positive (=placebo) to a negative (=nocebo) meaning; (b)
evaluated items for face and content validity of the new version
of the questionnaire; and (c) valued the content accuracy, survey
structure and word clarity (De Leeuw et al., 2008). In a first
phase each member of the panel worked independently; in a
second phase they discussed and confronted using a thinking
aloud strategy. The final survey tool was composed by 20
items available in Italian (Supplementary File 1) and English
(Supplementary File 2).
The survey was piloted as a self-administered questionnaire
in a convenient sample of 15 OMTs (North, n = 5; Center, n = 5;
South of Italy, n = 5), not included in final sample of the study. To
investigate potential filled in issues (e.g., vague questions, unclear
words), a telephone debriefing session (De Leeuw et al., 2008)
among the involved 15 OMTs was performed. The outcome of
the pilot study was positive: the sample referred that the questions
did not need further explanation, and the words were simple and
easy to understand: thus, no changes to the items were applied.
Questionnaire Implementation
The self-administered questionnaire was divided into three
sections (A, B, and C). In the first section (A) the socio-
demographic variables were collected using two open-ended
questions (age, years of clinical practice) and eight closed single-
choice questions (gender, Italian region, workplace, type of
work, setting, profile of patients cared for, field of work, hours
of work per week).
The section (B) included variables exploring the relation
between different CFs and nocebo-related effects by using
two closed single-choice questions. Specifically, the questions
investigated the frequency of nocebo-related effects in the OMTs’
experience (answers from “never” to “always”) and the beliefs
about the weight of specific CFs (Likert from 0 “not at all” to 4
“a lot of”) in triggering nocebo-related effects.
The last section (C) included variables exploring the
knowledge of participants about nocebo-related effects and
how they managed them in the clinical practice. In particular,
eight closed single-choice questions investigated: (a) the
communication (n = 2); (b) the mechanisms of action (n = 1); (c)
the management issues (n = 2); (d) the education (n = 2); and (e)
the definition (n = 1) of CFs and nocebo-related effects.
Data Collection Procedure
The SurveyMonkey (Survey-Monkey, Palo Alto, California)1 was
selected as an online survey tool. Orthopedic manual therapists
were invited to participate in the study through an email (De
Leeuw et al., 2008) in which the aim of the study and the
anonymity of data were explained. The email also pointed
that the informed consent to participate in the study would
have been provided by clicking on the survey link (Eysenbach
and Wyatt, 2002). Participants could change their answers and
review them before submitting the final survey, but they were
required to answer all questions to prevent missing data. The
survey took responders between 5 and 10 minutes to complete:
this response time was chosen to optimize responses rate
(Fan and Yan, 2010).
Data were downloaded and stored in an encrypted computer.
Only the principal investigator could have access to the
information achieved during all stages of the study. All data
(name and email address) were anonymized to ensure privacy
and data protection (De Leeuw et al., 2008) leaving the
participants’ identities concealed to researchers (Eysenbach and
Wyatt, 2002). No incentives were offered to participants and
the attendance was voluntary (Eysenbach and Wyatt, 2002). The
OMTs who did not complete the questionnaire were encouraged
to participate in the survey by an email reminder at 2, 4, and
8 weeks after the first contact.
Data Analysis
To review answers accuracy, data were transferred from
SurveyMonkey to Excel spreadsheet. For descriptive statistic,
continuous variables were reported using mean, standard
deviation (SD) and confidence intervals at 95% (95% CI); whereas
absolute frequency and percentage described dichotomous,
1www.surveymonkey.com
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nominal and ordinal variables, coming from single answer
questions. Age and years of clinical practice were transformed
into ordinal variables considering a decade as variable level for
the analysis of correlations.
As this study is the first on nocebo in physiotherapy,
we analyzed all the possible relations between the socio-
demographic characteristics of the sample (section A, intended
as the dependent variables) and answers to section (B) and (C),
intended as independent variables, were analyzed with Cramer’s
V, which is a statistic analysis tool that measures strength and
directions of associations used when one or both the independent
and dependent variables consists of unordered categories with
more than two levels. Only correlation values higher than the
threshold (>0.50) (Cohen, 1988) were accepted and reported in
the study. R software was used for the data analysis (R Core
Team, 2020) with the packages psych (Revelle, 2017) and ggplot2
(Wickham, 2009).
RESULTS
Flow of Participants Through the Study
From the sample of 1288 OMTs, 791 responses were received
(61.4%). Most participants were male (n = 473; 59.8%; 95% CI
56.3–63.2) and their average age was 31.0 ± 7.1 years. Overall,
70.9% of OMTs (n = 561; 95% CI 67.6–74.0) reported to work in
the North of Italy. Respondents had an average clinical experience
of 7.4 ± 6.3 years. The majority of them was employed in
private health care settings (n = 676; 85.5%; 95% CI 82.8–87.8)
as a freelance professional (n = 569; 71.9%; 95% CI 68.6–75.0)
working between 32 and 45 h per week (n = 433; 54.7%; 95% CI
51.2–58.2) in an outpatient clinic (n = 607; 76.7%; 95% CI 73.6–
79.6). A high proportion of OMTs worked in the musculoskeletal
field (n = 718; 90.8%; 95% CI 88.5–92.7) with adult patients (646;
81.7%; 95% CI 78.8–84.3). The participants’ demographics are
described in Table 1.
Definition of Nocebo-Related Effects
Orthopedic manual therapists were asked how they would
define nocebo-related effects: the most selected option was
“psychosocial effects of the context around therapy and patient
with specific biological bases” (n = 571; 72.2%; 95% CI 68.9–
75.3). Some OMTs opted for “health procedure effects able to
create negative expectations” (n = 162; 20.5%; 95% CI 17.7–
23.5), whereas the less frequent response was “adverse responses
observed in people of the control group of randomized clinical
trials” (n = 58; 7.3%; 95% CI 5.7–9.4).
Mechanisms of Action of
Nocebo-Related Effects
Analyzing the mechanisms of action that are believed to
explain nocebo-related effects, the most frequent response was
“associative learning (e.g., conditioning)” (n = 228; 28.8%; 95%
CI 25.7–32.1), followed by “patient’s expectation” (n = 207;
26.2%; 95% CI 23.2–29.4). Other options were (in descending
TABLE 1 | Socio-demographic variables.
Demography Values 95% CI
Years, mean (SD) 31.0 (7.1) 30.5–31.5
Years of clinical practice, mean (SD) 7.4 (6.3) 7.0–7.8
Gender, n (%)
Male 473 (59.8) 56.3–63.2
Female 318 (40.2) 36.8–43.7
Italian region, n (%)
North 561 (70.9) 67.6–74.0
Center 161 (20.4) 17.6–23.4
South 69 (8.7) 6.9–11.0
Workplace, n (%)
Private health care settings 676 (85.5) 82.8-87.8
Public health care settings 115 (14.5) 12.2-17.2
Type of work, n (%)
Freelance professional 569 (71.9) 68.6–75.0
Employee 222 (28.1) 25.0–31.4
Setting, n (%)
Outpatient clinic 607 (76.7) 73.6–79.6
Hospital 123 (15.5) 13.1–18.3
Residential care (nursing home) 61 (7.7) 6.0–9.9
Profile of patients, n (%)
Adults 646 (81.7) 78.8–84.3
Older people 134 (16.9) 14.4–19.8
Pediatrics 11 (1.4) 0.7–2.6
Field of work, n (%)
Musculoskeletal 718 (90.8) 88.5–92.7
Neurological 57 (7.2) 5.5–9.3
Cardiorespiratory 11 (1.4) 0.7–2.6
Oncological 3 (0.4) 0.1–1.2
Uro-gynecological 2 (0.3) 0.0–1.0
Hours of work per week, n (%)
1–15 18 (2.3) 1.4–3.6
16–30 175 (22.1) 19.3–25.2
31–45 433 (54.7) 51.2–58.2
46–60 146 (18.5) 15.8–21.4
>60 19 (2.4) 1.5–3.8
n, number of participants;%, percentage; SD, standard deviation; 95% CI, 95%
confidence interval; >, more.
order): “psychological traits” (n = 125; 15.8%; 95% CI 13.4–
18.6), “previous experiences” (n = 95; 12.0%; 95% CI 9.9–
14.5), “social learning” (n = 66; 8.3%; 95% CI 6.6–10.5), and
“neurophysiological” mechanisms (n = 52; 6.6%; 95% CI 5.0–8.6).
The less chosen option regarding the mechanism of action was
“genetic” (n = 18; 2.3%; 95% CI 1.4–3.6).
Beliefs About CFs as Triggers of
Nocebo-Related Effects
Participants reported a high level of conviction toward CFs
(mean = 2.4 out of 4; 95% CI 2.4–2.5) as triggers of nocebo-related
effects. Specifically, the most important CFs were (in descending
order): “lack of empathetic therapeutic alliance with the patient”
(mean = 3.3; 95% CI 3.3–3.4), “patient’s negative expectation”
(mean = 3.3; 95% CI 3.2–3.4), “patient’s previous negative
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experience” (mean = 3.2; 95% CI 3.1–3.2); “negative verbal
communication” (mean = 3.1; 95% CI 3.0-3.1); and “negative
attitudes and pessimistic behavior” (mean = 3.1; 95% CI 3.0-3.1).
Less influent CFs were (in descending order): “printed
information about the therapy” (mean = 1.9; 95% CI 1.8–1.9);
“hidden therapy” (mean = 1.8; 95% CI 1.7–1.8); “inaccurate
design” (mean = 1.7; 95% CI 1.7–1.8), “lack of patient’s familiarity
with the therapy” (mean = 1.6; 95% CI 1.6–1.7); “lack of uniform”
(mean = 1.6; 95% CI 1.5–1.7). A complete description of CFs
capable to trigger nocebo-related effects is reported in Table 2.
Frequency of Nocebo-Related Effects
Orthopedic manual therapists reported that nocebo-related
effects were present in their clinical experience with a frequency
of (in descending order): “sometimes” (n = 336; 42.5%; 95% CI
39.0–46.0), “often” (n = 286; 36.2%; 95% CI 32.8–39.6), “rarely”
(n = 147; 18.6%; 95% CI 16.0–21.5), “always” (n = 11; 1.4%; 95%
CI 0.7–2.5) and “never” (n = 11; 1.4%; 95% CI 0.7–2.5).
Communication of Nocebo-Related
Effects
When asked how participants were used to communicate
nocebo-related effects to the patient, the most frequent answer
was “balance the positive features of the therapy with the negative
ones” (n = 403; 50.9%; 95% CI 47.4–54.5), whereas few OMTs
reported to “do not say anything” (n = 77; 9.7%; 95% CI 7.8–12.1).
Regarding when they communicate nocebo-related effects,
most of OMTs informed their patients “during the decision of the
therapeutic plan” (n = 338; 42.7%; 95% CI 39.3–46.3). The option
“during the clinical examination” (n = 17; 2.1%; 95% CI 1.3–3.5)
was the less chosen. The detailed communication strategies used
in daily practice are reported in Table 3.
Management of Nocebo-Related Effects
The most adopted intervention to avoid nocebo-related effects
was “teach and train patient’s strategies to manage adverse
events” (n = 313; 39.6%; 95% CI 36.2–43.1). The less chosen
responses were “refer to evidence-based information on the
Internet” (n = 14; 1.8%; 95% CI 1.0–3.0) and “adopt a gradual
reduction of the treatment in a hidden way” (n = 9; 1.1%; 95%
CI 0.6–2.2).
When asked which clinician-patient communication was
mainly adopted to avoid nocebo-related effects, the majority of
OMTs replied “evaluate and modify patient’s anxieties, doubts
and expectations” (n = 298; 37.7%; 95% CI 34.3–41.2), whereas a
minor number of OMTs chose “ask the patient to give questions”
(n = 17; 2.1%; 95% CI 1.3–3.5). Table 4 presented the overall
responses about the management of nocebo-related effects.
Education of Nocebo-Related Effects
The majority of OMTs considered their education about nocebo-
related effects as “medium” (n = 381; 48.2%; 95% CI 44.6–51.7),
followed by “limited” (n = 218; 27.6%; 95% CI 24.5–30.8) and
“very good” (n = 165; 20.9%; 95% CI 18.1–23.9). Some of them
considered it “absent” (n = 20; 2.5%; 95% CI 1.6–3.9) and a few
“complete” (n = 7; 0.9%; 95% CI 0.4–1.9).
Most participants believed that the management of nocebo-
related effects should be taught in “bachelor degree” (n = 622;
78.6%; 95% CI 75.6–81.4). Many respondents suggested that
the education should be preferably provided during a “post-
graduation diploma” (n = 77; 9.8%; 95% CI 7.8–12.1) and some
of them as “e-learning/advanced distance learning” (n = 55; 7.0%;
95% CI 5.3–9.0). The less chosen options were “master of science
degree” (n = 22; 2.8%; 95% CI 1.8–4.2), “Philosophy doctor
degree” (n = 15; 1.9%; 95% CI 1.1–3.2).
Correlation Between Variables
Strength of association between variables was weak, with a
Cramer’s V below (from 0.1 to 0.3) the established threshold
(Cramer’s V < 0.5) in all correlations, such as between socio-
demographic variables of section (A) and responses given in
section (B) and (C) of the survey.
DISCUSSION
This is the first national survey that investigates the knowledge
of Italian OMTs regarding nocebo-related effects and CFs. The
main finding of this study suggests that OMTs are aware of the
presence of nocebo-related effects in their clinical practice and
that these effects can be triggered by CFs.
According to current evidences (Miller and Miller, 2015;
Carlino and Benedetti, 2016), Italian OMTs defined nocebo-
related effects as due to the negative psychosocial context around
the therapy, composed of both internal and external elements to
the patient and capable to influence his/her therapeutic outcomes
through specific biological bases, thus reflecting an adequate
knowledge of the topic.
Our participants identified in the associative learning and
expectations the main mechanisms of action explaining nocebo-
related effects. As reported in several studies, the repetitive
negative associations of the therapy with CFs (e.g., specific color
and shape of a medicine) (Faasse and Martin, 2018), similar
and negative previous experiences (Colloca et al., 2010; Testa
and Rossettini, 2016) and verbal messages highlighting negative
expectations (e.g., “you will receive a medication which will
increase your pain”) (Blasini et al., 2017) can trigger nocebo-
related effects both in healthy people (Colloca et al., 2008;
Bingel et al., 2011) and in patients (Damien et al., 2018).
Instead, OMTs considered genetic as the less influent mechanism
contrary to evidence that have identified the involvement of
specific genes such as catechol-O-methyltransferase (COMT) in
the development of nocebo-related effects (Wendt et al., 2014).
Italian OMTs reported that they encountered nocebo-related
effects in their clinical practice, and they are convinced that these
effects are triggered by specific CFs present in the therapeutic
context. The most influential CFs were those mainly related to the
encounter between patient and physiotherapist, that represents
a fundamental moment in which biopsychosocial components
are investigated, symbolizing the foundations for the therapeutic
alliance in physiotherapy (Miciak et al., 2018; Moore et al., 2020).
In detail, the lack of empathetic therapeutic alliance with the
patient (Fuentes et al., 2014), the patient’s negative expectations
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4 n (%); 95%
CI
3 n (%); 95%
CI
2 n (%); 95%
CI
1 n (%); 95%
CI
0 n (%); 95%
CI
A: Weak professional reputation (e.g.,
qualification, expertise of physiotherapist)










A. Lack of uniform (e.g., white coat of
physiotherapist)










A. Negative attitudes and pessimistic
behavior (e.g., toward a patient’s dysfunctions)










B. Patient’s negative expectation (e.g.,
toward a physiotherapy treatment)










B. Patient’s previous negative
experience (e.g., toward a physiotherapy
treatment)






5 (0.6); 0.2–1.6 40 (5.1);
3.7–6.9
C. Negative verbal communication (e.g.,
medical language, lack of positive messages
associated with the treatment)











communication (e.g., closing posture,
gestures, absence of eye contact, facial
expressions)










C. Lack of empathetic therapeutic alliance
with the patient (e.g., lack of active listening)









D. Information about the therapy delivered
by other patients (e.g., negative
communicated or observed responses)










D. Printed information about the
therapy (e.g., medical leaflets)










D. Information about the therapy from the
media (e.g., internet, social media, television
news)










D. Hidden therapy (e.g., impossibility for the
patient to see when the therapy is delivered)










D. Sudden interruption of the therapy (e.g.,
to attend other patients or colleagues)










D. Marketing of the therapy (e.g., cost,
brand, color, shape)










D. Lack of patient’s familiarity with the
therapy (e.g., new therapy)










D. Lack of patient-centered approach (e.g.,
not shared-decision of physiotherapy treatment)










D. Inappropriate physical contact with the
patient (e.g., invasiveness of the touch)










E. Lack of comfortable setting (e.g.,
inappropriate lighting, temperature)











architecture (e.g., inappropriate highlights,
indicators)










E. Inaccurate design (e.g., absence of
decorations, ornaments, colors)










n, number of participants; 95% CI, 95% confidence interval; 0, not at all; 1, few; 2, enough; 3, much; 4, a lot of; A, physical therapist domain; B, patient domain; C,
physical therapist-patient relationship domain; D, therapy domain; E, healthcare setting domain.
as well as previous negative experience(s) (Testa and Rossettini,
2016), the physiotherapist’s negative verbal communication,
attitudes and pessimistic behavior (Oliveira et al., 2012) have been
all shown to negatively influence subjective (e.g., pain, anxiety)
and objective (e.g., function, disability) outcomes in patient
with musculoskeletal pain. Instead, the printed information
about the therapy and the hidden administration of the therapy
(Wand et al., 2012), the inaccurate design (Schweitzer et al.,
2004), the lack of patient’s familiarity about the therapy (Faasse
and Martin, 2018) and the lack of physiotherapist’s uniform
(Mercer et al., 2008) have been considered less influent CFs
likelihood because of a OMTs’ poor of awareness of their negative
clinical importance. Overall, our findings suggest to OMTs the
need to consider CFs as triggers of nocebo-related effects capable
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TABLE 3 | Communication of nocebo-related effects.
Communication n (%) Values 95% CI
How do you mainly communicate nocebo effects to the patient?
Balance the positive features of the therapy with the negative ones 403 (50.9) 47.4–54.5
Carefully explain the effects and the role played by the negative context 226 (28.6) 25.5–31.9
Minimize negative information on nocebo-related effects by not reporting all the elements 85 (10.7) 8.7–13.2
Do not say anything 77 (9.7) 7.8–12.1
When do you mainly communicate nocebo effects to the patient?
During the decision of the therapeutic plan 338 (42.7) 39.3–46.3
During the administration of the therapy 221 (27.9) 24.9–31.2
Do not communicate anything 114 (14.4) 12.1–17.1
During the anamnesis 56 (7.1) 5.4–9.1
During the formulation of the diagnosis 45 (5.7) 4.2–7.6
During the clinical examination 17 (2.1) 1.3–3.5
n, number of participants;%, percentage; 95% CI, 95% confidence interval.
TABLE 4 | Management of nocebo-related effects.
Management of nocebo-related effects, n (%) Values 95% CI
Which interventions do you mainly use to avoid nocebo effects?
Teach and train patient’s strategies to manage nocebo-related effects 313 (39.6) 36.2–43.1
Optimize expectations toward treatment and nocebo-related effects 196 (24.8) 21.8–28.0
Explain nocebo-related effects using illustrative methods (e.g., videos, figures, graphs and percentages) and simple language 110 (13.9) 11.6–16.6
Present first the positive features of the treatment and then the negative ones 71 (9.0) 7.1–11.2
Do not do anything 46 (5.8) 4.3–7.7
Use pre-treatments with a reduced percentage of nocebo-related effects (e.g., active or inert treatment-test) 32 (4.0) 2.8–5.7
Refer to evidence-based information on the Internet 14 (1.8) 1.0–3.0
Adopt a gradual reduction of the treatment in a hidden way 9 (1.1) 0.6–2.2
Which clinician-patient communication do you mainly use to avoid nocebo-related effects?
Evaluate and modify patient’s anxieties, doubts and expectations 298 (37.7) 34.3–41.2
Use an empathic and authentic communication style 233 (29.5) 26.3–32.8
Provide adequate information (e.g., pathology, diagnosis, treatment, adverse events) 145 (18.3) 15.7–21.2
Investigate previous experiences of therapeutic failure 38 (4.8) 3.5–6.6
Ask the patient to summarize the information provided to avoid misunderstanding 34 (4.3) 3.0–6.0
Use images and narrative 26 (3.3) 2.2–4.8
Ask the patient to give questions 17 (2.1) 1.3–3.5
n, number of participants;%, percentage; 95% CI, 95% confidence interval.
to negatively impact patients’ outcomes in accordance to the
evidences reported in medicine (Colloca and Barsky, 2020) and
physiotherapy (Rossettini et al., 2020).
OMTs communicated nocebo-related effects mainly during
the decision of the therapeutic plan, balancing the positive
features of the treatment with the negative ones. According to
evidence available, no information should be omitted during
the discussion of the positive and negative effects of treatment,
offering to clinicians three options of communication: (a)
explaining and highlighting as first the desired positive treatment
effects (Kleine-Borgmann and Bingel, 2018); (b) reframing the
information on negative effects in a positive way (Enck et al.,
2013; Bingel, 2014); and (c) informing patients about the
presence of nocebo-related effects and their relevance in the
treatment (Crichton and Petrie, 2015). Only few OMTs did
not inform their patients, resulting in a non-transparent and
deceptive communication that threatens the respect of ethical
principles behind the therapy administration (e.g., the principle
of autonomy, the informed consent) (Colloca and Finniss, 2012;
Klinger et al., 2017).
Italian OMTs referred they managed nocebo-related effects by
teaching and training patient’s strategies to control unintended
negative effects of treatment. Orthopedic manual therapists
also reported having adopted an empathic and authentic
communication style aimed to evaluate and modify patients’
anxieties, doubts and expectations. Overall, these results highlight
how an adequate interaction between the clinician and the
patient is essential to minimize nocebo-related effects (Dieppe
et al., 2016; Blasini et al., 2018), underlining the importance of
education (Wijma et al., 2016; Hoon et al., 2017). During the
therapeutic encounter, it has been shown that an appropriate
education can influence the outcome (e.g., pain, function) (Louw
et al., 2016) and improve the patients’ self-efficacy (Jönsson et al.,
2018) in patients with musculoskeletal pain.
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Most OMTs considered to have a medium level of education
about nocebo-related effects suggesting that this topic should
be taught mainly during the bachelor degree, as suggested
internationally (Evers et al., 2018) and previously reported among
clinicians (Rossettini et al., 2018b; Palese et al., 2019) and students
(Cadorin et al., 2020) in physiotherapy and in nursing field.
Strengths and Weakness of the Study
The current survey presented some strengths. A high response
rate was achieved (61.4%), confirming the willingness of OMTs
to participate in this study. Moreover, authors have adopted an
online survey to understand the opinion of the target population.
The methodological choice was previously used in surveys on
placebo-related effects and CFs representing a valid tool aimed to
capture the perspective of a large sample of healthcare providers
(Rossettini et al., 2018b).
As a weakness, a group of Italian physiotherapists specialized
in OMT educated mostly in managing musculoskeletal pain
in the private healthcare settings (AIFI, 2020) were involved.
Therefore, their response can be not generalizable to non-
specialized physiotherapists (e.g., not OMTs), working in other
fields (e.g., neurology) and employed in different settings (e.g.,
hospital), thus suggesting future studies in this field. Most of
participants worked full-time, in the North of Italy and for less
than 10 years: these are all factors that could have influenced
beliefs and knowledge regarding nocebo effects, limiting the
generalizability of findings (Rossettini et al., 2018b). Moreover,
data were self-reported introducing a social and recall bias that
can have affected the findings. Furthermore, the format of asking
participants how to define nocebo effects with a closed question
with three options could have given some prior cues to the
participant, thus biasing their reported knowledge on the topic.
Finally, despite the anonymity was guaranteed some participants
might have misreported some data (Eysenbach, 2004;
Palese et al., 2019).
CONCLUSION
In summary this national survey shows that OMTs are aware of
the presence of nocebo-related effects in their clinical practice and
that these effects can be triggered by CFs. From a policymakers’
perspective, it is recommended to ensure an appropriate
knowledge on nocebo-related effects among healthcare providers
aimed at minimizing their negative impact in clinical practice,
including this topic in undergraduate education.
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